A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial

Affiliations

• ¹ Faculty of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (K.H., K.A.).
• ² Center for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan (H.W., Y.K., K. Todaka).
• ³ Division of Cardiovascular Medicine, Kobe University Hospital, Japan (Y.T.).
• ⁴ Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan (N.I.).
• ⁵ Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan (T.I.).
• ⁶ Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (S.Y., N.Y.).
• ⁷ Department of Cardiology, Nagoya University Hospital, Japan (T.M, S.A.).
• ⁸ Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Japan (M.H., S.M.).
• ⁹ Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan (Y.T.).
• ¹⁰ Department of Cardiology, Tokyo Medical University, Japan (J.Y.).
• ¹¹ Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan (K. Tatsumi).
• ¹² Division of Respiratory and Cardiovascular Innovative Research, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan (I.T.).
• ¹³ Department of Cardiology, Keio University School of Medicine, Tokyo, Japan (K.F.).
• ¹⁴ International University of Health and Welfare, Okawa, Japan (H.T.).